PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Yingjia Sun

Shanghai Chest Hospital

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · JOURNAL ARTICLE

Clinical outcomes of SMARCA4-deficient thoracic tumor patients and therapeutic value of immune checkpoint inhibitors in advanced stage patients

BMC Cancer

Single-centre retrospective cohort with small advanced-stage subgroups (n=16 per arm) and exploratory analyses; unadjusted PFS benefit for ICIs did not survive adjustment, and authors explicitly state findings are hypothesis-generating rather than confirmatory.

PreliminaryShuya Mu Metastasis and Carcinoma Case Studies Qing Jiang

Reported

Sample size total98

Advanced-stage cohort, ICI-contai…16

Advanced-stage cohort, chemothera…16

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support